Screening outcomes in older US women undergoing multiple mammograms in community practice: Does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

Journal of the National Cancer Institute

Volumn 105, Issue 5, 2013, Pages 334-341

  Braithwaite, Dejana ^a   Zhu, Weiwei ^c   Hubbard, Rebecca A ^c,d   O'Meara, Ellen S ^c   Miglioretti, Diana L ^c,d   Geller, Berta ^e   Dittus, Kim ^e   Moore, Dan ^a   Wernli, Karen J ^c   Mandelblatt, Jeanne ^f   Kerlikowske, Karla ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER STAGING; CHARLSON COMORBIDITY INDEX; COMORBIDITY; FALSE POSITIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMMUNITY HEALTH SERVICES; COMORBIDITY; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MASS SCREENING; MEDICARE; NEOPLASM STAGING; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; SEER PROGRAM; TIME FACTORS; UNITED STATES;

EID: 84874871753     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs645     Document Type: Article

References (37)

1. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885-892.
2. Schonberg MA, Silliman RA, Marcantonio ER. Weighing the benefits and burdens of mammography screening among women age 80 years or older. J Clin Oncol. 2009;27(11):1774-1780.
3. Bellizzi KM, Breslau ES, Burness A, Waldron W. Prevalence of cancer screening in older, racially diverse adults: still screening after all these years. Arch Intern Med. 2011;171(22):2031-2037.
4. Schonberg MA, McCarthy EP, Davis RB, Phillips RS, Hamel MB. Breast cancer screening in women aged 80 and older: results from a national survey. J Am Geriatr Soc. 2004;52(10):1688-1695.
5. Heflin MT, Oddone EZ, Pieper CF, Burchett BM, Cohen HJ. The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc. 2002;50(10):1651-1658.
6. Yasmeen S, Xing G, Morris C, Chlebowski RT, Romano PS. Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis. Cancer. 2011;117(14):3252-3261.
7. Smith-Bindman R, Quale C, Chu PW, Rosenberg R, Kerlikowske K. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older? Med Care. 2006;44(5):463-470.
8. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285(21):2750-2756.
9. Hillner BE, Mandelblatt J. Caring for older women with breast cancer: can observational research fill the clinical trial gap? J Natl Cancer Inst. 2006;98(10):660-661.
10. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-726.
11. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99-119.
12. Badgwell BD, Giordano SH, Duan ZZ, et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol. 2008;26(15):2482-2488.
13. McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc. 2002;50(6):1061-1068.
14. Mandelblatt JS, Wheat ME, Monane M, Moshief RD, Hollenberg JP, Tang J. Breast cancer screening for elderly women with and without comorbid conditions. A decision analysis model. Ann Intern Med. 1992;116(9):722-730.
15. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738-747.
16. Ballard-Barbash R, Taplin SH, Yankaskas BC, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997;169(4):1001-1008.
17. Land LH, Dalton SO, Jensen MB, Ewertz M. Impact of comorbidity on mortality: a cohort study of 62, 591 Danish women diagnosed with early breast cancer, 1990-2008. Breast Cancer Res Treat. 2012;131(3):1013-1020.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
19. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-1251.
20. Klabunde CN, Harlan LC, Warren JL. Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients. Med Care. 2006;44(10):921-928.
21. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol. 1997;50(6):725-733.
22. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258-1267.
23. American Joint Committee on Cancer. Manual for Staging of Cancer. 6th ed. Philadelphia: JB Lippincott; 2002.
24. Hubbard RA, Miglioretti DL, Smith RA. Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res. 2010;19(5):429-449.
25. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA. 1995;273(2):149-154.
26. White E, Miglioretti DL, Yankaskas BC, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst. 2004;96(24):1832-1839.
27. Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care. 2005;43(2):132-140.
28. Vaeth PA, Satariano WA, Ragland DR. Limiting comorbid conditions and breast cancer stage at diagnosis. J Gerontol A Biol Sci Med Sci. 2000;55(10):M593-600.
29. Mandelblatt JS, Gold K, O'Malley AS, et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med. 1999;28(4):418-425.
30. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Tenyear risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338(16):1089-1096.
31. Xu JL, Fagerstrom RM, Prorok PC, Kramer BS. Estimating the cumulative risk of a false-positive test in a repeated screening program. Biometrics. 2004;60(3):651-660.
32. US Census Bureau. Current Population Reports, P25-1095. Table US-EST90INT-04 - Intercensal Estimates of the United States Resident Population by Age Groups and Sex, 1990-2000: Selected Months, September 2002. http://www.census .gov/popest/archives/EST90INTERCENSAL/ US-EST90INT-04.html;
33. 2010 Census Redistricting Data (P.L. 94-171) Summary File, http://www.census.gov/rdo/data/2010-census-redistricting- data-pl-94-171- summary-files.html.
34. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007;17(8):584-590.
35. Zelen M, Feinleib M. On the theory of screening for chronic diseases. Biometrika. 1969;56(3):601-614.
36. Autier P, Hery C, Haukka J, Boniol M, Byrnes G. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol. 2009;27(35):5919-23.
37. Mandelblatt JS, Schechter CB, Yabroff KR, et al. Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med. 2005;20(6):487-496.